Evidence map›Paper›PMID 39227837›Full record

ArticleVirology journal2024

Fetal Zika virus inoculation in macaques revealed control of the fetal viral load during pregnancy.

Charles Egloff, Claire-Maëlle Fovet, Jessica Denis, Quentin Pascal, Laetitia Bossevot, Sophie Luccantoni, Marco Leonec, Nathalie Dereuddre-Bosquet, Isabelle Leparc-Goffart, Roger Le Grand and 4 more

Abstract read
In one paragraph

Article in Virology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Charles EgloffCenter for Immunology of Viral, Auto-Immune, Hematological and Viral Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, 92265, Fontenay aux Roses, France.
Claire-Maëlle FovetCenter for Immunology of Viral, Auto-Immune, Hematological and Viral Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, 92265, Fontenay aux Roses, France.
Jessica DenisUnité interactions hôtes-pathogènes, Institut de Recherche Biomédicale des Armées, 91223, Brétigny-sur-Orge, France.
Quentin PascalCenter for Immunology of Viral, Auto-Immune, Hematological and Viral Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, 92265, Fontenay aux Roses, France.
Laetitia BossevotCenter for Immunology of Viral, Auto-Immune, Hematological and Viral Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, 92265, Fontenay aux Roses, France.
Sophie LuccantoniCenter for Immunology of Viral, Auto-Immune, Hematological and Viral Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, 92265, Fontenay aux Roses, France.
Marco LeonecCenter for Immunology of Viral, Auto-Immune, Hematological and Viral Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, 92265, Fontenay aux Roses, France.
Nathalie Dereuddre-BosquetCenter for Immunology of Viral, Auto-Immune, Hematological and Viral Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, 92265, Fontenay aux Roses, France.
Isabelle Leparc-GoffartUnité des Virus Émergents (UVE: Aix-Marseille Univ-Corsica Univ-IRD 190-Inserm 1207-IRBA), 13005, Marseille, France.
Roger Le GrandCenter for Immunology of Viral, Auto-Immune, Hematological and Viral Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, 92265, Fontenay aux Roses, France.
Guillaume André DurandUnité des Virus Émergents (UVE: Aix-Marseille Univ-Corsica Univ-IRD 190-Inserm 1207-IRBA), 13005, Marseille, France.
Cyril BadautUnité des Virus Émergents (UVE: Aix-Marseille Univ-Corsica Univ-IRD 190-Inserm 1207-IRBA), 13005, Marseille, France.
Olivier PiconeService de gynécologie-obstétrique, Hôpital Louis Mourier, AP-HP, IAME INSERM U1137, Université de PARIS, Paris, France.
Pierre RoquesCenter for Immunology of Viral, Auto-Immune, Hematological and Viral Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, 92265, Fontenay aux Roses, France. pierre.roques@cea.fr.

Funding

ARS Iles de France 2020-10
6 · The paper itself

Abstract

backgroundEarly pregnancy Zika virus (ZIKV) infection is associated with major brain damage in fetuses, leading to microcephaly in 0.6-5.0% of cases, but the underlying mechanisms remain largely unknown.

methodsTo understand the kinetics of ZIKV infection during fetal development in a nonhuman primate model, four cynomolgus macaque fetuses were exposed in utero through echo-guided intramuscular inoculation with 10

resultsZIKV was transmitted from the fetus to the mother and then replicate in the peripheral blood of the mother from week 1 to 4 postexposure. Infected fetal brains tended to be smaller than those of controls, but not the femur lengths. High level of viral RNA ws found after the first month in brain tissues and placenta. Thereafter, there was partial control of the virus in the fetus, resulting in a decreased number of infected tissue sections and a decreased viral load. Immune cellular and humoral responses were effectively induced.

conclusionsZIKV infection during the second trimester of gestation induces short-term brain injury, and although viral genomes persist in tissues, most of the virus is cleared before delivery.

Indexed as

BrainDisease Models, AnimalFetusPregnancy Complications, InfectiousViral LoadZika VirusZika Virus InfectionAnimalsFemaleInfectious Disease Transmission, VerticalMacaca fascicularisPlacentaPregnancyRNA, ViralRNA, ViralMicrocephalyNeutralizing antibodiesNonhuman primate modelTORCH infectionViral clearanceZika virus

Identifiers

PMID39227837
PMCPMC11373269

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.